Investor Presentaiton slide image

Investor Presentaiton

Targeted commercial strategy for Shield launch in 2024 INVESTOR 20 DAY 23 High concentration of Medicare lives Maximize ASP States with coverage mandates post ACS guidelines GUARDANT™ *American Cancer Society (ACS) 누 Strong utilization of non-invasive screening Phlebotomy access Maximize efficiency & productivity 121
View entire presentation